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10. Witting N, Duno M, Petri H, Krag T, Bundgaard H, Kober L, et al. characterized by psychomotor delay, progressive microcephaly, cerebellar atrophy, and variable brainstem involvement. 1 At least 10 subtypes of PCH have been recognized. PCH type 1 is a particularly severe subgroup that includes early anterior horn motor neuron degeneration, encompassing the phenotypic spectrum of spinal muscular atrophy (SMA) plus disorders. 2, 3 Clinically, it presents with a variable degree of generalized congenital weakness and hypotonia, respiratory failure, feeding difficulties, and contractures, as well as cerebellar and brainstem signs that are usually recognized later. 1, 4 The age of onset among PCH1 patients may range from antenatal detection with polyhydramnios and fetal akinesia, to a presentation within the first months of life with mild hypotonia and delayed milestones. [1] [2] [3] Life expectancy is severely reduced, but survival beyond the age of 10 years has been reported. 1, 5, 6 Recently, EXOSC3 gene mutations were shown to underlie approximately 30-50% of PCH1 cases in some cohorts, 1,2 being particularly prevalent in patients from Romani pedigrees.
3,4 They have not been associated with other PCH subtypes. EXOSC3 encodes the human exosome component 3 protein, also known as ribosomal RNA-processing protein 40 (RRP40), a key element on RNA exosome complex. It has been shown to play a critical role in RNA processing and tis hypothesized to potentially influence gene expression. 5, 7 To date, single point mutations and deletions have been identified, [1] [2] [3] [4] and some reports showed a tendency for a more severe phenotype with poor neurological outcomes and early death in patients harboring the c.92G>C (p.Gly31Ala) mutation. 1, [3] [4] [5] [6] Previous histochemical analysis of muscle biopsies from PCH1 patients harboring different EXOSC3 mutations have shown neurogenic aspects such as marked type grouping and round atrophic fibers resembling those seen in SMN1-associated SMA. 4, 5 However, no particular myofibrillar alterations have been described. Here we report three unrelated patients harboring the same EXOSC3 mutation showing remarkably similar and distinctive ultrastructural findings in muscle biopsies.
MATERIALS AND METHODS
We searched Unité de Morphologie Neuromusculaire pathology records for genetically determined EXOSC3-mutated PCH1 patients who have undergone diagnostic muscle biopsies. Clinical information was obtained through medical record review. EXOSC3 mutation analysis, amplification primers and conditions as well as sequencing methods were performed according to Wan et al. 2 and Biancheri et al. 5 Muscle biopsies were analyzed through conventional histoenzymological techniques, and ultrastructural studies performed according to international standards (see Supplementary Material, which is available online).
RESULTS

Patient 1 was a male, born of nonconsanguineous
French parents with Romani ancestry. The pregnancy was complicated by polyhydramnios and limited fetal mobility. After a term birth with slightly low birth weight but normal head circumference, the examination showed a severe areflexic hypotonia with ventilator-dependent respiratory insufficiency and feeding difficulties. Brain magnetic resonance imaging (MRI) revealed severe PCH and a thin corpus callosum. Atrioventricular dissociation and occasional complete blocks were noted. The patient died on the 9th day of life from respiratory failure.
Patient 2 was a female, born of consanguineous Romani parents living in Argentina, with severe congenital hypotonia, an absent suck reflex and respiratory difficulties resulting in early respiratory infections, atelectasis and dependence on mechanical ventilation. At 5 months of age, examination displayed slight microcephaly, profound muscle weakness with arreflexia, tongue fasciculations, strabismus, and nystagmus. Creatine kinase (CK) levels were normal. A progressive pontocerebellar atrophy with moderate cerebral cortical atrophy was noted in sequential brain MRIs. The patient remained bedridden and ventilator-dependent until the age of 4 years, when she died from respiratory failure.
Patient 3 was a female born to Argentinian consanguineous parents of Hungarian Romani ancestry. She presented with generalized congenital hypotonia, swallowing difficulties, and laryngeal stridor requiring intensive care unit management. The examination showed mild microcephaly, partial eye contact with brief fixation, nystagmus but no strabismus, and severe areflexic hypotonia. CK levels were normal. Electrodiagnostic testing was indicative of a motor neuron disorder. At age 4 months, a brain MRI revealed severe PCH. The patient continued to demonstrate severe generalized weakness requiring permanent mechanical ventilation, and remained poorly attentive. She died at the age of 7 months due to multi-organ failure.
None of the patients presented with contractures at birth. All tested negative for SMN1 deletions or mutations. No mutations were found in the congenital myopathy-related genes RYR1, ACTA1, TPM2, TPM3, and TNNT1 in patient 1. EXOSC3 gene screening or exome sequencing revealed the same homozygous c.92G>C (p.Gly31Ala) missense mutation in exon 1 in all patients.
Quadriceps muscle biopsies were performed on day 9 in patient 1, in month 7 in patient 2, and in month 1 in patient 3. In patient 1, hematoxylin and eosin (H&E) stain revealed great variability of fiber size diameter with numerous round small fibers distributed randomly through the fascicles, a few normal sized fibers, and rare large fibers. No type grouping was observed. Modified Gömöri trichrome (mGT) stain revealed discrete reddish inclusions resembling small rods in roughly 10% of the fibers with very small diameter (Fig. 1A) . Oxidative stains showed a few fibers with mild subsarcolemmal myofibrillar disorganization, but no peripheral halos as usually seen in SMA biopsies (Fig. 1B) . Patients 2 and 3 displayed complete fascicle atrophy, few large fibers, and a marked type grouping, highly suggesting a neurogenic process (Fig. 1C) .
In all patients, electron microscopy revealed numerous fibers with striking sarcomeric disorganization, involving the entire section of the fiber or affecting predominantly subsarcolemmal regions, producing a caps-like aspect (Fig. 2A) . Most areas were composed of tangles of disordered sarcomeres with Z-line thickening and absent mitochondrion (Fig. 2B,C) . In the most extensively affected regions, only sarcomeric remnants were observed, consisting of small fragments of thickened Z material bound to thin filaments (Fig. 2D) . Small nemaline bodies with random orientation and typical cross-sectional square structure were often observed (Fig. 2E) . Rare subsarcolemmal areas were composed solely of disorganized thin filaments where Z-line material was absent. These findings were more evident in patients 1 and 2. No major basal membrane detachment was observed, except for a small area in one single fiber in patient I (Fig. 2F) .
DISCUSSION
We present 3 unrelated PCH1 patients sharing the same EXOSC3 mutation and describe their common features of profound sarcomeric disorganization with numerous small rods. Our patients displayed the typical phenotype consistently reported for other EXOSC3-related PCH1 patients, namely the cognitive and neuromuscular signs at birth and progressive deterioration. Of interest, although the severe phenotype associated with the c.92G>C mutation was observed in all our patients, the most striking signs were exhibited by patient 1, accounting for the previously recognized EXOSC3 phenotypic variability 3 and suggesting that other factors may affect clinical severity.
PCH1 patients show histopathological features of muscle fibers atrophy and type grouping, resembling those of SMA with SMN1 mutations. 4, 5 Muscles of SMA patients usually show global preservation of internal architecture, but mild to moderate denervationrelated disorganization and reduction of sarcomeric structures in the smallest atrophic fibers have been demonstrated in a cohort of genetically uncharacterized SMA patients. 8 Two of our patients demonstrated histopathology similar to SMA patients, but patient 1 also showed reddish inclusions on mGT staining, suggesting nemaline rods. Electron microscopy confirmed the presence of Z-line material thickening, compatible with small nemaline bodies. At least 1 previous report of a patient with a clinical diagnosis of PCH1 showed Z-line abnormalities and nemaline bodies in few muscle fibers, but the patient was genetically uncharacterized. 9 Furthermore, mild widening of the Z-line material and small rods have been described in one patient from a pathologic cohort of PCH2 patients. 10 Although our patients demonstrated different and more severe pathology, in particular sarcomeric segment remnants and Z-line thickening (Fig. 2D,E) , these findings could suggest that sarcomeric disruption itself might not be specific for a PCH diagnosis.
Nemaline bodies, however, are almost exclusively associated with congenital myopathies, namely with nemaline myopathies, 11 but are nonspecific because they can rarely occur as a secondary phenomenon in other miscellaneous disorders such as myofibrillar myopathy, 12 mitochondrial disorders, 13 human immunodeficiency virus-related myopathy, 14 and sporadic late-onset nemaline myopathy. 15 Nevertheless, the presence of nemaline bodies in genetically determined childhood-onset myopathies other than nemaline myopathies is exceptionally rare. To date, there is insufficient evidence to associate EXOSC3 mutations with typical nemaline myopathies, but our findings suggest that their screening might be adequate in early-onset hypotonic patients with nemaline bodies, particularly when central nervous system involvement and motor neuron degeneration are apparent.
This report systematically describes sarcomeric disruption and rod structures as distinctive features of muscle biopsies from three EXOSC3-mutated patients. While deemed consistent through our uniform genetic cohort, further studies are needed to assess their reproducibility and specificity. Because SMN1-associated SMA is the main differential diagnosis in the context of neonatal hypotonia, and given that a definitive diagnosis may be delayed until pontocerebellar atrophy signs are recognized, muscle biopsy is an important resource in the diagnostic evaluation, and ultrastructural study may provide early clues to a diagnosis of PCH1.
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